Risk factor analysis for postoperative nausea and vomiting in patients undergoing transcatheter aortic valve implantation.

Risk factor analysis for postoperative nausea and vomiting in patients undergoing transcatheter aortic valve implantation. - Risk factor analysis for postoperative nausea and vomiting in patients undergoing transcatheter aortic valve implantation.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000026614

Enrollment

Registered

2017-03-20

Start date

2017-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who performed tranfemoral TAVI between January 2016 and February 2017 under general anesthesia in Osaka City University Hospital.

Exclusion criteria

Exclusion criteria: Patients who could not be extubeted in the operating room.

Design outcomes

Primary

Measure	Time frame
Postoperative nausea and vomiting within 24h after surgery	—

Countries

Japan

Contacts

Public ContactTakashi Juri

Osaka City University Graduate School of Medicine Anesthesiology

anesth@med.osaka-cu.ac.jp06-6645-2186

Outcome results